https://www.fdaweb.com/depomed-wants-nucynta-er-andas-changed/
Depomed Wants Nucynta ER ANDAs Changed
Sep 15, 2026 - Depomed is petitioning FDA to delay granting final approval to ANDAs citing Nucynta ER (tapentadol) as the reference-listed drug until the sponsors submit a...
depomedwantsnucyntaandaschanged
https://www.prnewswire.com/news-releases/this-mornings-technical-outlook-on-drug-makers-stocks----synergy-pharma-depomed-united-therapeutics-and-novo-nordisk-300573753.html
This Morning's Technical Outlook on Drug Makers Stocks -- Synergy Pharma, Depomed, United...
/PRNewswire/ -- In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free tailored Stock...
this morningtechnicaloutlookdrugmakers